Investors
Don't miss any news, subscribe to our press releases.
Rights issue 2021
Summary of the rights issue
- If fully subscribed, the rights issue will provide the Company with approximately SEK 67.6 million before issue costs.
- The net proceeds will mainly be used to further develop and commercialize the Company's existing project portfolio, develop new projects and finance the Company's ongoing operations.
- Shareholders who were registered in the share register maintained by Euroclear Sweden AB on the record date August 13, 2021 will receive one (1) subscription right for each share held on the record date. Two (2) subscription rights entitle the holder to subscribe for one (1) new share at a subscription price of SEK 5.34 per share.
- The subscription period for the rights issue runs from August 17, 2021 to August 31, 2021.
- The Rights Issue is covered to 1.4 percent by subscription commitments and to 98.6 percent by underwriting commitments. The rights issue is thus fully guaranteed.
Preliminary timetable for the Rights Issue
All dates refer to 2021
August 11, 2021 | Last day of trading in the Company's share with the right to receive subscription rights |
12 August 2021 | First day of trading in the Company's share without the right to receive subscription rights |
August 13, 2021 | Record date for receipt of subscription rights Publication of the Company's interim report for January - June 2021 |
August 16, 2021 | Date of publication of the Prospectus |
August 17, 2021 to August 31, 2021 inclusive | Subscription period for the Rights Issue |
August 17, 2021 until the end of 26 August 2021 | Trading in subscription rights |
September 2, 2021 | Estimated date for announcement of the outcome of the Rights Issue |
August 17, 2021 until around week 37 2021 | Trade in GVA |
Documents for download
Sprint Bioscience AB (publ) prospectus
Press release - Sprint Bioscience announces the Board of Directors' intention to decide on a fully guaranteed rights issue
Press release - Sprint Bioscience announces the Board of Directors' intention to decide on a fully guaranteed rights issue
Sprint Bioscience publishes prospectus in connection with fully guaranteed rights issue
Sprint Bioscience announces the Board's intention to decide on a fully guaranteed rights issue
Application form - Subscription with subscription rights Sprint Bioscience
Application form - Subscription without subscription rights Sprint Bioscience